MedTrace Logo

Particulate Corticosteroid Versus Non-particulate Corticosteroid for Sacroiliac Joint Injection

NCT03166761 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2024-07-10

Study results available
· View outcomes & findings →

Summary

Comparing two different corticosteroids (dexamethasone and triamcinolone) for use in sacroiliac joint injections

Conditions

  • Sacro-Iliac Spondylosis

Interventions

DRUG

Dexamethasone

Dexamethasone injection into the sacroiliac joint

DRUG

Triamcinolone Acetonide

Triamcinolone injection into the sacroiliac joint

Sponsors & Collaborators

  • Vanderbilt University Medical Center

    lead OTHER

Principal Investigators

  • Byron Schneider · Assistant professor

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-14
Primary Completion
2023-02-28
Completion
2023-02-28
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03166761 on ClinicalTrials.gov